This Article Full Text Full Text (PDF) Correction (v33,p1171) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weir, N. U. Articles by Warlow, C. P. Search for Related Content PubMed PubMed Citation Articles by Weir, N. U. Articles by Warlow, C. P. Related Collections Antiplatelets Other Stroke Treatment - Medical Emergency treatment of Stroke Computerized tomography and Magnetic Resonance Imaging Rehabilitation, Stroke

(Stroke. 2001;32:1370.)
© 2001 American Heart Association, Inc.

Original Contributions

Variations Between Countries in Outcome After Stroke in the International Stroke Trial (IST)

N. U. Weir, MBChB; P. A. G. Sandercock, DM; S. C. Lewis, PhD; D. F. Signorini, PhD; C. P. Warlow, MD on behalf of the IST Collaborative Group

From the Department of Neurology, Royal Hallamshire Hospital, Sheffield (N.U.W.), and Department of Clinical Neurosciences, Western General Hospital, Edinburgh (P.A.G.S., S.C.L., D.F.S., C.P.W.), UK.

Correspondence to Professor P.A.G. Sandercock, Department of Clinical Neurosciences, Western General Hospital, Crewe Rd, Edinburgh, EH4 2XU, Scotland. E-mail pags{at}skull.dcn.ed.ac.uk

Background and Purpose—This study describes the large variations in outcome after stroke between countries that participated in the International Stroke Trial and seeks to define whether they could be explained by variations in case mix or by other factors.

Methods—We analyzed data from the 15 116 patients recruited in Argentina, Australia, Italy, the Netherlands, Norway, Poland, Sweden, Switzerland, and the United Kingdom. We compared crude case fatality and the proportion of patients dead or dependent at 6 months; we used logistic regression to adjust for age, sex, atrial fibrillation, systolic blood pressure, level of consciousness, and number of neurological deficits. We used the frequency of prerandomization head CT scan and prescription of aspirin at discharge to indicate quality of care.

Results—The differences in outcome (all treatment groups combined) between the "best" and "worst" countries were very large for death (171 cases per 1000 patients) and for death or dependency (375 cases per 1000 patients). The differences were somewhat smaller after adjustment for case mix (160 and 311 cases per 1000 patients, respectively). Process of care may have accounted for some but not all of the residual variation in outcome.

Conclusions—Adjustment for case mix explained only some of the variation in outcome between countries. The residual differences in outcome were too large to be explained by variations in care and most likely reflect differences in unmeasured baseline factors. These findings demonstrate the need to achieve balance of treatment and control within each country in multinational randomized controlled stroke trials and the need for caution in the interpretation of nonrandomized comparisons of outcome after stroke between countries.

Key Words: case fatality rate • cerebrovascular disorders • disability evaluation • outcome • randomized controlled trials

This article has been cited by other articles:

				K. Kuwabara, S. Matsuda, Y. Imanaka, K. Fushimi, H. Hashimoto, and K. Ishikawa The effect of age and procedure on resource use for patients with cerebrovascular disease J Health Serv Res Policy, January 1, 2008; 13(1): 26 - 32. [Abstract] [Full Text] [PDF]

				D W J Dippel National variations in mortality and functional outcome: should we be worried? J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 288 - 288. [Full Text] [PDF]

				L J Gray, N Sprigg, P M W Bath, P Sorensen, E Lindenstrom, G Boysen, P P De Deyn, P Friis, D Leys, R Marttila, et al. Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST) J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 327 - 333. [Abstract] [Full Text] [PDF]

				L. De Wit, K. Putman, E. Dejaeger, I. Baert, P. Berman, K. Bogaerts, N. Brinkmann, L. Connell, H. Feys, W. Jenni, et al. Use of Time by Stroke Patients: A Comparison of Four European Rehabilitation Centers Stroke, September 1, 2005; 36(9): 1977 - 1983. [Abstract] [Full Text] [PDF]

				H Markus Variations in care and outcome in the first year after stroke: a Western and Central European perspective J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1660 - 1661. [Full Text] [PDF]

				C D A Wolfe, K Tilling, A Rudd, M Giroud, and D Inzitari Variations in care and outcome in the first year after stroke: a Western and Central European perspective J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1702 - 1706. [Abstract] [Full Text] [PDF]

				J. M. Wardlaw, J. Seymour, J. Cairns, S. Keir, S. Lewis, and P. Sandercock Immediate Computed Tomography Scanning of Acute Stroke Is Cost-Effective and Improves Quality of Life Stroke, November 1, 2004; 35(11): 2477 - 2483. [Abstract] [Full Text] [PDF]

				P. U. Heuschmann, P. L. Kolominsky-Rabas, J. Roether, B. Misselwitz, K. Lowitzsch, J. Heidrich, P. Hermanek, C. Leffmann, M. Sitzer, M. Biegler, et al. Predictors of In-Hospital Mortality in Patients With Acute Ischemic Stroke Treated With Thrombolytic Therapy JAMA, October 20, 2004; 292(15): 1831 - 1838. [Abstract] [Full Text] [PDF]

				P. U. Heuschmann, K. Berger, B. Misselwitz, P. Hermanek, C. Leffmann, M. Adelmann, H.-J. Buecker-Nott, J. Rother, B. Neundoerfer, and P. L. Kolominsky-Rabas Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality: The German Stroke Registers Study Group Stroke, May 1, 2003; 34(5): 1106 - 1112. [Abstract] [Full Text] [PDF]